Prochlorperazine
3 NDCs across 2 manufacturers|2 Generic,1 Brand
Prochlorperazine is used to treat anxiety disorders, dementia, nausea, psychotic disorders, schizophrenia and vomiting, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Nov 24, 1993. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Prochlorperazine across 14,000 claims for 10,000 beneficiaries.
Prochlorperazine is available as 3 NDCs from 2 manufacturers (2 generic, 1 brand), with NADAC prices from $4.87 to $6.74 per EA — a 39% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
2G / 1B
Manufacturers
2
competing in market
Price Spread
$4.87 – $6.74
per EA
7d Activity
avg +1.5% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Cosette Pharmaceuticals, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Phenothiazine class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing PROCHLORPERAZINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COMPRO 25 MG SUPPOSITORY | $6.7423 per EA | +0.19% |
PROCHLORPERAZINE 25 MG SUPP | $4.8651 per EA | +2.11% |
PROCHLORPERAZINE 25 MG SUPP | $4.8651 per EA | +2.11% |
Frequently Asked Questions
What is Prochlorperazine used to treat?
Prochlorperazine is used to treat anxiety disorders, dementia, nausea, psychotic disorders, schizophrenia and vomiting, per the National Library of Medicine's MED-RT classification.
When did Prochlorperazine become available as a generic?
FDA approved the first generic Prochlorperazine (ANDA) on Nov 24, 1993. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Prochlorperazine?
In 2024, Medicare Part D spent $2 million on Prochlorperazine across 14,000 claims for 10,000 beneficiaries.
How many Prochlorperazine products are on the market?
The Prochlorperazine drug market contains 3 NDCs from 2 manufacturers — 2 generic and 1 brand product.
What is the price range for Prochlorperazine?
NADAC reference prices for Prochlorperazine range from $4.8651 to $6.7423 per EA — a 39% difference between cheapest and most expensive.
Is generic Prochlorperazine cheaper than brand?
The average generic NADAC for Prochlorperazine is $4.8651 per EA, versus $6.7423 for brand-labeled products — generic is about 28% cheaper on average.
Which manufacturers make Prochlorperazine?
2 manufacturers list Prochlorperazine in NADAC. Ranked by number of NDCs, the largest are Cosette Pharmaceuticals, Inc. (2), Padagis US LLC (1).
How has the price of Prochlorperazine changed recently?
Over the past 7 days, 3 Prochlorperazine NDCs rose and 0 fell, with a market-wide average change of +1.5%.